Search research articles
Contact Us
Filters
Showing results (131-140 of 1,833) with videos related to
Page
of 184
Sort By:
Mabs
|
February 20, 2015
Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics
Amita Datta-Mannan, Arunkumar Thangaraju, Donmienne Leung, et al.
Mabs
|
February 19, 2015
Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis
Lin Cheng, Xian Tang, Li Liu, et al.
Mabs
|
May 10, 2023
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
Kerry A Whalen, Kavya Rakhra, Naveen K Mehta, et al.
Mabs
|
April 9, 2021
Calculation of therapeutic antibody viscosity with coarse-grained models, hydrodynamic calculations and machine learning-based parameters
Pin-Kuang Lai, James W Swan, Bernhardt L Trout
Mabs
|
July 14, 2020
Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain
Joschka Bauer, Sven Mathias, Sebastian Kube, et al.
Mabs
|
April 26, 2021
A platform-agnostic, function first-based antibody discovery strategy using plasmid-free mammalian expression of antibodies
Ruijun Zhang, Ponraj Prabakaran, Xiaocong Yu, et al.
Mabs
|
April 27, 2021
N-terminal selective conjugation method widens the therapeutic window of antibody-drug conjugates by improving tolerability and stability
Min Ji Ko, Daehae Song, Juhee Kim, et al.
Mabs
|
May 15, 2023
Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis
Susanne Klint, Joachim Feldwisch, Lindvi Gudmundsdotter, et al.
Mabs
|
April 26, 2012
Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display
Christian Votsmeier, Hanna Plittersdorf, Oliver Hesse, et al.
Mabs
|
April 26, 2012
Monoclonal antibodies: longitudinal prescribing information analysis of hypersensitivity reactions
Konstantin Kleyman, Debra S Weintraub
Page
of 184
Search research articles
Search
Showing results (131-140 of 1,833) with videos related to
Sort By:
Page
of 184
Mabs
|
February 20, 2015
Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics
Amita Datta-Mannan, Arunkumar Thangaraju, Donmienne Leung, et al.
Mabs
|
February 19, 2015
Monoclonal antibodies specific to human Δ42PD1: A novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis
Lin Cheng, Xian Tang, Li Liu, et al.
Mabs
|
May 10, 2023
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
Kerry A Whalen, Kavya Rakhra, Naveen K Mehta, et al.
Mabs
|
April 9, 2021
Calculation of therapeutic antibody viscosity with coarse-grained models, hydrodynamic calculations and machine learning-based parameters
Pin-Kuang Lai, James W Swan, Bernhardt L Trout
Mabs
|
July 14, 2020
Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain
Joschka Bauer, Sven Mathias, Sebastian Kube, et al.
Mabs
|
April 26, 2021
A platform-agnostic, function first-based antibody discovery strategy using plasmid-free mammalian expression of antibodies
Ruijun Zhang, Ponraj Prabakaran, Xiaocong Yu, et al.
Mabs
|
April 27, 2021
N-terminal selective conjugation method widens the therapeutic window of antibody-drug conjugates by improving tolerability and stability
Min Ji Ko, Daehae Song, Juhee Kim, et al.
Mabs
|
May 15, 2023
Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis
Susanne Klint, Joachim Feldwisch, Lindvi Gudmundsdotter, et al.
Mabs
|
April 26, 2012
Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display
Christian Votsmeier, Hanna Plittersdorf, Oliver Hesse, et al.
Mabs
|
April 26, 2012
Monoclonal antibodies: longitudinal prescribing information analysis of hypersensitivity reactions
Konstantin Kleyman, Debra S Weintraub
Page
of 184